Research record: Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing.
Published in Hemasphere; first publication date 2026-06-18. PMID 42325850.
This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.